PARIS (AFP) - Four-time Tour de France winner Chris Froome failed a drugs test for asthma medication during the Vuelta race in September, cycling's governing body UCI said on Wednesday.
The British Team Sky rider had twice the permitted level of legal asthma drug Salbutamol in his body.
The UCI has asked Froome to provide more information but has not suspended him.
Team Sky said the 32-year-old rider had suffered from asthma since childhood and had been affected by symptoms during the Vuelta a Espana, the Tour of Spain, which he went on to win.
But the team said he had taken no more than the allowable amount of Salbutamol.
"During the final week of the Vuelta, Chris experienced acute asthma symptoms. On the advice of the Team Sky doctor, he used an increased dosage of Salbutamol (still within the permissible doses) in the run-up to the 7 September urine test," Team Sky said.
The team said Froome had declared his use of the medication, adding: "The notification of the test finding does not mean that any rule has been broken."
Froome said the UCI was "absolutely right" to scrutinize the test results.
He said that during the race he had "followed the team doctor's advice to increase my Salbutamol dosage".
Froome was notified of the test on September 20, the day he finished third in the world time-trial championship in Bergen, Norway.
The test will raise new questions about British cycling following the scandal surrounding the only previous British Tour de France winner, Bradley Wiggins, over his use of so-called therapeutic use exemptions (TUEs).
****** Froome said the UCI was "absolutely right" to scrutinise the test results.